Preliminary evidence also suggests that priming of T cells with DCs exposed to NIPP-treated A375 melanoma cell lysates results in higher cytotoxic activity of CD8+ T cells against live A375 cells compared to untreated controls [32]. This evidence concerns the gene CD8A and melanoma.